ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the following March investor conferences:
| Barclays Global Healthcare Conference | ||
| Date: | Tuesday, March 11, 2025 | |
| Fireside chat: | 12:30 p.m. ET | |
| Place: | Loews Miami Beach Hotel, Miami, Fla. | |
| Jefferies Biotech on the Beach Summit | ||
| Date: | Wednesday, March 12, 2025 | |
| Place: | Ritz-Carlton South Beach, Miami, Fla. | |
Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinators.
A live audio webcast of the Company’s fireside chat at the Barclays Global Healthcare Conference can be accessed here or by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of the webcast will be available for 60 days on the Company’s website following the conference.
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
Our diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving …
